Collaboration - May 4, 2017
AstraZeneca, Pieris Pharmaceuticals collaborate
AstraZeneca announces a strategic collaboration in respiratory diseases with Pieris Pharmaceuticals to develop novel inhaled drugs that leverage Pieris’ Anticalin platform. Under the collaboration, Pieris will be responsible for advancing its preclinical lead candidate, PRS-060 into Phase I clinical trials in 2017. PRS-060 is an Anticalin against interleukin-4 receptor alpha (IL-4Ra) with potential in asthma. […]
Collaboration - March 27, 2017
Aprea enters research collaboration
Aprea Therapeutics announces a collaboration with Memorial Sloan Kettering Cancer Center to study the effects of reactivation of tumor suppressor protein p53 by APR-246. The goal of the collaboration is to evaluate and characterize preclinical efficacy of APR-246 in combination with multiple other anti-cancer agents and across multiple tumor types. The Principal Investigator of the […]
Collaboration - March 17, 2017
AstraZeneca & Circassia enter strategic collaboration
AstraZeneca has entered a strategic collaboration with Circassia Pharmaceuticals for the development and commercialisation of Tudorza and Duaklir in the US. Tudorza and Duaklir are inhaled respiratory medicines for the treatment of chronic obstructive pulmonary disease (COPD). Tudorza was approved and launched in the US in 2012. Duaklir is expected to be submitted for US […]
Collaboration - March 1, 2017
Vironova participate in big data and computational science project
Vironova is participating in the research project “Hierarchical Analysis of Temporal and Spatial Image Data” which the Swedish foundation for Strategic Research (SSF) has announced 29 M SEK in funding for. Other partners in the project are Astra Zeneca and SciLifeLab and the project is headed by Professor Carolina Wählby at Uppsala University Department of […]
Collaboration - February 9, 2017
Elekta enters partnership with ESTRO Cancer Foundation
Elekta recently entered into a partnership with the ESTRO [European Society for Radiotherapy & Oncology] Cancer Foundation (ECF) to contribute – hand in hand with various other partners in academia and industry – to the foundation’s mission to ensure that “every patient in Europe will have access to state-of-the-art radiation therapy”. “Elekta’s addition as a […]
Collaboration - February 8, 2017
Two new Swedish industry research centres with life science focus
The Swedish Foundation for Strategic Research (SSF) is investing 400 million SEK in four industrial research centres, and two of these are focusing on challenges within life science; nucleotide based drugs and personalized diabetes medicine. SSF has decided to establish four industry research centres with the purpose to enable groundbreaking innovation coming from external industrial challenges. […]
